The Patient is at the Center of everything we do: by providing education and price transparency, extraordinary clinical expertise, and proprietary clinical solutions we’ll ensure patients control their fertility journey and achieve their best possible outcome.

The Patient is at the Center of Everything We Do

The Patient
is at the Center
of Everything We Do

Progyny's employer benefit plans provide innovative care built to support healthy families. The Progyny suite of smart fertility services allows employers to provide the most effective treatment options to their employees, the first time - saving time, money, and preventing unnecessary risk.
IVFAdvantage is the only direct-to-consumer IVF bundled treatment plan developed by patients for patients, providing negotiated rates with the option to finance. With hundreds of locations across the US, IVFAdvantage plans help make IVF treatment cycles more affordable.
EggBanxx is the first direct-to-consumer national network of fertility doctors specializing in egg freezing for fertility preservation. EggBanxx Egg Freezing Parties have captured the attention of the media, while normalizing the conversation and making information gathering fun and smart. Plans come with the ability to finance and save 15% off of clinic pricing.
The Eeva test is the first and only FDA-cleared test to aid in embryo selection. It was designed to provide your IVF team with reliable, objective information to select embryos with greater confidence as they strive to do everything possible to improve your odds of a successful pregnancy.
Launched in 2009, FertilityAuthority.com is a comprehensive, interactive online network for those seeking fertility and treatment information, advice, referrals and consultation.
With more than 68,000 members & more than 4 million posts, FertileThoughts is the world's largest social media site driven by user-generated content and organic traffic. The FT community is over 17 years old and still going strong.

As Seen On

About Us

Progyny is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions. We are committed to helping ensure that patients control their fertility journey and achieve the best possible outcome. Our all-inclusive digital platform guides patients through the fertility health journey and empowers them to select from an elite network of fertility doctors offering exclusive pricing, build a customized fertility health plan and make a purchase with the ease of a few clicks. Patients are able to select plan options including elective egg freezing, IVF treatment options, and the Eeva™ Test.

Our portfolio includes:

  • Eeva Test, a non-invasive time-lapse imaging system to consistently and objectively assess early embryo development milestones.
  • IVFAdvantage, Progyny's no-restriction IVF package plan, offers bundled treatment plans with pricing transparency, scheduling assistance, and preferred appointment times at top clinics across the country.
  • EggBanxx, is on a mission to empower young, professional women to take charge of their reproductive health. EggBanxx provides women with affordable and accessible egg freezing options through its network of 116 fertility doctors across the United States.
  • FertilityAuthority.com, the country’s leading patient-matching technology platform serving the fertility industry through education, patient support, pricing transparency and financing.

Management Team

Gina Bartasi
Chief Executive Officer

A seasoned entrepreneur and thought leader, Gina brings more than 20 years of experience to the digital healthcare industry with a proven track record of building new businesses from the ground up. Gina is known for analyzing market conditions and pivoting quickly with a focus on financial performance. She has a long history of spotting and capitalizing on market trends, where she’s launched several key brands and digital media properties including Fertility Authority, a suite of sites providing financing and support for both IVF and egg freezing patients. With 1M+ monthly visitors a month, Fertility Authority built the foundation of patient and clinic relationships to transform the fertility market-place. Gina is a graduate of UNC-Chapel Hill and Harvard Business School (OPM 33).

Ed Neumann
Chief Financial Officer

Ed Neumann joins Progyny with 25+ years of experience in finance and operations, direct to consumer and eCommerce business. Ed was formerly the Chief Financial Officer at Borderfree overseeing the growth and expansion of the business through its initial public offering and subsequent acquisition by Pitney Bowes. As a proven leader with expertise in scaling and accelerating growth in commerce businesses, Ed brings a wealth of knowledge and strategic planning to Progyny, Inc.

Earlier in his career, Ed held management positions with HR Logic, Inc. (formerly NovaCare Employee Services, Inc.), Crown Cork & Seal Company, and Ernst & Young LLP.

He holds a B.S. in Accounting from West Chester University in Pennsylvania.

George Nassef
Chief Technology Officer

A proven leader in technology and engineering, Mr. Nassef brings over 15+ years of experience in leadership, strategy, budgeting, management, architecture, engineering, and programming to the team. George’s career includes being the former CTO/CIO of HotJobs, MIVA.com, and Biztravel.com, as well as working with American Airlines, SABRE and startups like Namely and Latest Edge. With a hands-on approach, George has perfected his skills in open source technologies, cloud, scalable web, mobile development and big data collection. Managing teams of a few to a few hundred over the course of his career, growing and scaling a business, its products, its technology and its future growth plans is nothing new to George as he now spearheads Progyny’s product line development.

Karin Ajmani
President, Healthcare Services

Bringing a multitude of specialty health and managed care experience, Karin is leading Progyny’s employer and consumer benefits products. Her mission is to expand employer coverage of infertility services by providing a SMART solution that is a “win/win” for employers, patients and clinicians. Prior to joining Progyny, Karin was CEO of US Imaging for eight years, and previously served as CEO of CarePlus Health Plan, a managed care plan in NY, where she led the organization from inception in 1996 through its sale in 2005. Karin also serves on the boards of Pacific Child and Family, a national autism provider services company, and Citra Health, a leading healthcare technology company. Karin has a Masters in Public Health from Columbia Univ. and is a graduate of the Univ. of Pittsburgh.

Dr. Gary Harton
Senior Vice President, Clinical Affairs

Dr. Gary Harton began his commercial career performing business development roles with two promi-nent genetics companies, Illumina and BlueGnome. Gary has been involved in a number of exciting breakthroughs in the field of reproductive genetics including performing the first clinical preimplanta-tion genetic diagnosis (PGD) for an autosomal dominant disease (Marfan syndrome) and performing the first clinical PGD for spinal muscular atrophy. Gary is certified by the American Board of Bioanalysis (ABB), a member of American Society for Reproductive Medicine (ASRM), the European Society of Human Reproduction and Embryology (ESHRE), and Preimplantation Genetic Diagnosis International Society. He graduated from James Madison Univ. and received his Ph.D. at the Univ. of Kent, Canter-bury, UK.

Board of Directors

Gina Bartasi
Chief Executive Officer

A seasoned entrepreneur and thought leader, Gina brings more than 20 years of experience to the digital healthcare industry with a proven track record of building new businesses from the ground up. Gina is known for analyzing market conditions and pivoting quickly with a focus on financial performance. She has a long history of spotting and capitalizing on market trends, where she’s launched several key brands and digital media properties including Fertility Authority, a suite of sites providing financing and support for both IVF and egg freezing patients. With 1M+ monthly visitors a month, Fertility Authority built the foundation of patient and clinic relationships to transform the fertility market-place. Gina is a graduate of UNC-Chapel Hill and Harvard Business School (OPM 33).

Fred Cohen, M.D., D.Phil.
TPG Biotech

Prior to joining TPG Biotechnology in 2001, Dr. Fred Cohen, M.D., D.Phil., was a Professor of medicine, cellular and molecular pharmacology, biochemistry and biophysics and pharmaceutical chemistry at UCSF. In this context, he was Chief of the Division of Endocrinology and Metabolism and directed an active research program in the areas of prion biology, structure based drug design, bioinformatics and heteropolymer chemistry. Dr. Cohen is a Fellow of the Institute of Medicine of the National Academies, the American Academy of Arts and Sciences, American College of Physicians, a member of the American Society for Clinical Investigation and the Association of American Physicians, and the recipient of several awards and honors including the Burroughs-Wellcome New Initiatives in Malaria Award, the LVMH Science Pour L’Art Prize (shared with Stanley Prusiner), a Searle Scholars Award and Young Investigator Awards from the Endocrine Society and the Western Society for Clinical Investigation. He graduated magna cum laude from Yale University in 1978 and received his D.Phil from Oxford University as a Rhodes Scholar in 1980, his M.D. from Stanford Medical School as an American Cancer Society Postdoctoral Fellow in 1984 and his internal medicine and endocrinology training at UCSF. He joined TPG in 2001 to initiate TPG’s venture efforts in biotechnology and life sciences. He currently serves on the board of directors of: Acumen, Inc.; BioCryst, Inc. (Nasdaq: BCRX); CareDx, Inc. (Nasdaq: CDNA); Five Prime Therapeutics, Inc. (Nasdaq: FPRX); Genomic Health, Inc. (Nasdaq: GHDX); Rapid Micro Biosystems Inc.; Roka Bioscience, Inc. (Nasdaq: ROKA); Tandem Inc. (Nasdaq: TNDM); and Veracyte, Inc. (Nasdaq: VCYT).

Beth Seidenberg, M.D.
Kleiner Perkins Caufield & Byers

Dr. Beth Seidenberg, M.D., joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area. Beth was formerly the Senior Vice President, Global Development, and Chief Medical Officer at Amgen. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb and Merck & Co. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. In total, she introduced 10 innovative products to market and achieved over 40 regulatory approvals (including new indications and formulations) on a worldwide basis. She is currently on the Board of Directors of 3-V Biosciences, Arresto Biosciences, BioCryst Pharmaceuticals, Breathe Technologies, Epizyme, iPierian, Inc, and RedBrick Health. Her primary focus is in novel therapeutics to treat unmet medical needs.

Beth received her B.S. from Barnard College and her medical degree from the University of Miami School Of Medicine. Her post-graduate training was completed at Johns Hopkins and the National Institutes of Health.

Simeon George, M.D.
SR One

Dr. Simeon George, M.D., joined SR One in 2007 and leads SR One’s investment activities on the West Coast. Prior to joining SR One, Simeon was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. Simeon is a member of the Board of Directors of Anaphore, Auxogyn, Inc., Genocea Biosciences, HTG Molecular, Principia Biosciences and Semprus BioSciences.

Simeon received his B.A. in Neuroscience from the Johns Hopkins University, where he graduated Phi Beta Kappa. Simeon received his MD from the University of Pennsylvania School of Medicine and his M.B.A. (Mayer Scholar) from the Wharton School of the University of Pennsylvania.

Linda Mintz
Care Finders Total Care, LLC

Linda Mintz is the Co-Chairman of Care Finders Total Care, LLC, a leading home health care company with 5 offices in NJ, and over 2000 employees. Ms Mintz is also a managing partner at LCP Advisors, LLC, a business advisory firm that provides strategic growth strategies, merger and acquisitions advisory services, exit strategies, and operational, transactional and financing assistance to companies at all stages of business development, from start ups, to middle market and mature companies looking for an exit. Ms Mintz has represented clients in a variety of industries including consumer products, fashion, healthcare, financial services, specialty chemicals, hospitality, real estate and technology. Prior to forming LCP Advisors, Ms Mintz was a corporate lawyer at Weil, Gotshal & Manges and a partner at Greenberg Traurig, and has over 20 years of transactional experience in evaluating, structuring, negotiating and completing mergers, acquisitions, debt and equity offerings and restructuring transactions for both public and private companies. Ms. Mintz also founded and operated a health-oriented, specialty snack food company from 1991-1999. Ms. Mintz has also held investment banking and private equity positions with Citibank, N.A., and Lioness Capital Partners, LLC. She has been a frequent speaker at trade business conferences on growth strategies, capital raising, mergers and acquisitions and exit strategies for privately held companies. Ms. Mintz graduated with a Bachelor of Science and Management from Tulane University School of Business and earned her Doctorate of Jurisprudence from University of Miami.

Kathy Harris
Sharecare, Inc.

Kathy Harris serves as Senior Vice President Corporate Development of Sharecare, Inc., an interactive, social Q&A platform designed to greatly simplify the search for quality healthcare information and help consumers live their healthiest life. Prior to Sharecare, she was a General Partner at Noro-Moseley Partners, the oldest and one of the largest venture capital firms in the Southeastern US. She led the Firm’s business development efforts throughout the Southeast and Texas and also focused on its investment activities in the healthcare industry. Prior to Noro-Moseley, Kathy was a Partner at Technology Ventures, a venture capital firm focused on Internet and e-commerce companies, the National Marketing Manager of Sirrom Capital Corporation, where she oversaw all business development and loan origination activities and Senior Vice President of the Investment Banking Group at J.C. Bradford & Co. (now UBS). Over her career, she has invested in early and growth stage companies in a broad array of industries and has been involved in more than 100 investment banking transactions totaling over $2 billion. Kathy started her career at KPMG.

She serves on the Boards of the Clemson University Research Foundation, the Health Care Advisory Board of Vanderbilt’s Owen Graduate School of Management and The Women's Leadership Board at Harvard's Kennedy School of Government.

Contact Us